74 related articles for article (PubMed ID: 2837246)
1. N2-substituted guanine derivatives act as selective non substrate inhibitors of HSV I thymidine kinase.
Focher F; Sangalli S; Ciarrocchi G; Della Valle G; Talarico D; Rebuzzini A; Wright G; Brown N; Spadari S
Biochem Pharmacol; 1988 May; 37(9):1877-8. PubMed ID: 2837246
[No Abstract] [Full Text] [Related]
2. Structure-activity relationships of N2-substituted guanines as inhibitors of HSV1 and HSV2 thymidine kinases.
Hildebrand C; Sandoli D; Focher F; Gambino J; Ciarrocchi G; Spadari S; Wright G
J Med Chem; 1990 Jan; 33(1):203-6. PubMed ID: 2153203
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside analogs as non-substrate inhibitors of herpes simplex viruses thymidine kinase.
Focher F; Sandoli D; Hildebrand C; Sangalli S; Ciarrocchi G; Rebuzzini A; Pedrali-Noy G; Manservigi R; Wright G; Brown N
Methods Find Exp Clin Pharmacol; 1989 Sep; 11(9):577-82. PubMed ID: 2555637
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationships of N2-phenylguanines as inhibitors of herpes simplex virus thymidine kinases.
Gambino J; Focher F; Hildebrand C; Maga G; Noonan T; Spadari S; Wright G
J Med Chem; 1992 Aug; 35(16):2979-83. PubMed ID: 1323680
[TBL] [Abstract][Full Text] [Related]
5. N2-phenyldeoxyguanosine: a novel selective inhibitor of herpes simplex thymidine kinase.
Focher F; Hildebrand C; Freese S; Ciarrocchi G; Noonan T; Sangalli S; Brown N; Spadari S; Wright G
J Med Chem; 1988 Aug; 31(8):1496-500. PubMed ID: 2840499
[TBL] [Abstract][Full Text] [Related]
6. QSAR and molecular graphics analysis of N2-phenylguanines as inhibitors of herpes simplex virus thymidine kinases.
Gaudio AC; Richards WG; Takahata Y
J Mol Graph Model; 2000 Feb; 18(1):33-41. PubMed ID: 10935205
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibitors of herpes simplex virus thymidine kinase diminish reactivation of latent virus from explanted murine ganglia.
Leib DA; Ruffner KL; Hildebrand C; Schaffer PA; Wright GE; Coen DM
Antimicrob Agents Chemother; 1990 Jun; 34(6):1285-6. PubMed ID: 2168150
[TBL] [Abstract][Full Text] [Related]
8. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.
Fyfe JA; Keller PM; Furman PA; Miller RL; Elion GB
J Biol Chem; 1978 Dec; 253(24):8721-7. PubMed ID: 214430
[No Abstract] [Full Text] [Related]
9. Efficiency of phosphorylation of the cyclobut-G (A-69992) enantiomers by HSV-1 thymidine kinase does not correlate with their anti-herpesvirus activity.
Kohlbrenner WE; Carter CD; Fesik SW; Norbeck DW; Erickson J
Biochem Pharmacol; 1990 Dec; 40(11):R5-10. PubMed ID: 2176497
[No Abstract] [Full Text] [Related]
10. Modelling of guanine-derivative--protein interaction complexes as a basis of drug design.
Folkers G; Prota A; Merz A
Farmaco; 1995 Jun; 50(6):449-54. PubMed ID: 7669183
[TBL] [Abstract][Full Text] [Related]
11. Nucleoside analogues as highly potent and selective inhibitors of herpes simplex virus thymidine kinase.
Martin JA; Lambert RW; Merrett JH; Parkes KE; Thomas GJ; Baker SJ; Bushnell DJ; Cansfield JE; Dunsdon SJ; Freeman AC; Hopkins RA; Johns IR; Keech E; Simmonite H; Walmsley A; Wong Kai-In P; Holland M
Bioorg Med Chem Lett; 2001 Jul; 11(13):1655-8. PubMed ID: 11425530
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of herpes simplex virus thymidine kinases by 2-phenylamino-6-oxopurines and related compounds: structure-activity relationships and antiherpetic activity in vivo.
Manikowski A; Verri A; Lossani A; Gebhardt BM; Gambino J; Focher F; Spadari S; Wright GE
J Med Chem; 2005 Jun; 48(11):3919-29. PubMed ID: 15916444
[TBL] [Abstract][Full Text] [Related]
13. The chemotherapeutic exploitation of virus-specified enzymes.
Elion GB
Adv Enzyme Regul; 1980; 18():53-66. PubMed ID: 6255770
[No Abstract] [Full Text] [Related]
14. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance.
Darby G; Field HJ; Salisbury SA
Nature; 1981 Jan; 289(5793):81-3. PubMed ID: 6256650
[TBL] [Abstract][Full Text] [Related]
15. Non-nucleoside inhibitors of mitochondrial thymidine kinase (TK-2) differentially inhibit the closely related herpes simplex virus type 1 TK and Drosophila melanogaster multifunctional deoxynucleoside kinase.
Balzarini J; Hernández AI; Roche P; Esnouf R; Karlsson A; Camarasa MJ; Pérez-Pérez MJ
Mol Pharmacol; 2003 Feb; 63(2):263-70. PubMed ID: 12527796
[TBL] [Abstract][Full Text] [Related]
16. Selective modification of thymidine by dansyl group and biological effects of the dansyl derivatives.
Bonora GM; Palù G
Biochem Pharmacol; 1988 May; 37(9):1849-50. PubMed ID: 2837243
[No Abstract] [Full Text] [Related]
17. Comparison of thymidine kinase activities indiced in cells productively infected with herpesvirus saimiri and herpes simplex virus.
Honess RW; O'Hare P; Young D
J Gen Virol; 1982 Feb; 58(Pt 2):237-49. PubMed ID: 6278057
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1 alpha,2 beta,3 alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl] guanine.
Terry BJ; Cianci CW; Hagen ME
Mol Pharmacol; 1991 Oct; 40(4):591-6. PubMed ID: 1656194
[TBL] [Abstract][Full Text] [Related]
19. Understanding the binding of 5-substituted 2'-deoxyuridine substrates to thymidine kinase of herpes simplex virus type-1.
De Winter H; Herdewijn P
J Med Chem; 1996 Nov; 39(24):4727-37. PubMed ID: 8941385
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of the penciclovir analog 9-(4-[(18)F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET.
Alauddin MM; Shahinian A; Gordon EM; Bading JR; Conti PS
J Nucl Med; 2001 Nov; 42(11):1682-90. PubMed ID: 11696640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
